Tag: #nasdaq

Hub Group Expands Scope of Accounting Problems, Says 2023 and 2024 Audited Statements 'Should No Longer Be Relied On'

Hub Group's audit committee says audited financial statements for 2023 and 2024 were materially misstated and should not be relied on.

$HUBG, #hubgroup, #accounting, #restatement, #sec, #nasdaq

Lifeward Restores Nasdaq Compliance After Audit Committee Shortfall

Israeli exoskeleton maker Lifeward says Nasdaq has closed a governance deficiency after new audit committee appointments, as bid-price pressure persists.

#nasdaq, #lifeward, #medicaldevices, #corporategovernance, #delisting

MediaCo posts 40% revenue jump in 2025 as losses widen after EstrellaTV deal

Owner of Hot 97, WBLS and EstrellaTV reports $133.3M in 2025 revenue but a $66.2M loss, citing impairments, warrant swings and debt costs.

#broadcasting, #streaming, #earnings, #nasdaq, #multiculturalmedia

GoHealth Reports 55% Revenue Drop and $498 Million Loss as Medicare Broker Pulls Back

GoHealth posted a steep 2025 revenue decline and a $498M loss after cutting Medicare Advantage enrollments, taking big impairments, and facing Nasdaq warnings.

#medicareadvantage, #insurance, #nasdaq, #earnings, #healthcare

Workhorse’s first post‑Motiv earnings show revenue surge, deeper losses and a reshaped balance sheet

After merging with Motiv, Workhorse reported triple‑digit revenue growth and more deliveries in 2025, but widened losses and negative margins.

#workhorse, #electricvehicles, #earnings, #mergers, #nasdaq

Oramed Sells Oral-Insulin Unit to Lifeward, Takes Major Stake in Exoskeleton Maker

Oramed sells its oral drug unit to Lifeward, receiving shares, warrants, royalties and convertible notes—positioning it as a near-control shareholder.

#biotech, #medtech, #nasdaq, #exoskeleton, #convertiblenotes

Strategy keeps STRC preferred dividend at 11.5%, reinforcing high-yield funding for its bitcoin bet

Strategy maintained an 11.5% dividend on its STRC preferred shares, with payouts expected to be treated as return of capital, as it continues funding bitcoin buys.

#bitcoin, #preferredstock, #dividends, #nasdaq, #microstrategy

A Tale of Two Listings: FreeCast’s Tiny Direct Debut and PayPay’s $1.1 Billion Nasdaq Test

FreeCast begins trading via direct listing while Japan’s PayPay prepares a major U.S. IPO—together showing the uneven reopening of 2026’s listings market.

#ipo, #nasdaq, #fintech, #streaming, #softbank